https://campsiitestudy.com/
Campsiite Study: MPS II (Hunter Syndrome) Clinical Trial – REGENXBIO
Jun 6, 2023 - REGENXBIO is enrolling participants in a clinical trial of RGX-121, an investigational, one-time gene therapy for potential treatment of MPS II (Hunter...
mps ii hunterclinical trialstudysyndrome